GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (HAM:GS70) » Definitions » Total Liabilities

GSK (HAM:GS70) Total Liabilities : €53,149 Mil (As of Sep. 2024)


View and export this data going back to 1987. Start your Free Trial

What is GSK Total Liabilities?

GSK's Total Liabilities for the quarter that ended in Sep. 2024 was €53,149 Mil.

GSK's quarterly Total Liabilities declined from Mar. 2024 (€52,934.49 Mil) to Jun. 2024 (€52,354.94 Mil) but then increased from Jun. 2024 (€52,354.94 Mil) to Sep. 2024 (€53,149.47 Mil).

GSK's annual Total Liabilities declined from Dec. 2021 (€67,976.71 Mil) to Dec. 2022 (€57,548.36 Mil) and declined from Dec. 2022 (€57,548.36 Mil) to Dec. 2023 (€53,638.70 Mil).


GSK Total Liabilities Historical Data

The historical data trend for GSK's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Total Liabilities Chart

GSK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72,347.97 65,873.80 67,976.71 57,548.36 53,638.70

GSK Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55,945.16 53,638.70 52,934.49 52,354.94 53,149.47

GSK Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

GSK's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=24454.881+(17649.348+8818.29
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+2716.177)
=53,639

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=68490.614-14851.918
=53,639

GSK's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=25574.813+(15784.185+9373.5
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+2416.968)
=53,149

Total Liabilities=Total Assets (Q: Sep. 2024 )-Total Equity (Q: Sep. 2024 )
=69182.737-16033.271
=53,149

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GSK Total Liabilities Related Terms

Thank you for viewing the detailed overview of GSK's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


GSK Business Description

Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK Headlines

No Headlines